Scientists at Children’s Hospital of Philadelphia have developed a new open-source algorithm that can detect with high sensitivity disease-causing structural variants in the genome.

Children’s Hospital of Philadelphia’s Office of Diversity & Inclusion (ODI) wins 2019 Excellence Award for Outstanding Diversity Program.

Improving Understanding of the Connection Between Epstein-Barr Virus and Post-transplant Lymphoproliferative Disease

Pilot study looks for link between obesity and cardiovascular disease in pediatric chronic kidney disease.

Children’s Hospital of Philadelphia (CHOP) is proud to announce a partnership with The Enterprise Center, in conjunction with Philadelphia Housing Development Corporation (PHDC), to build the number of licensed contractors in Philadelphia and expand CHOP’s Community Asthma Prevention Program Plus Home Repairs (CAPP+) initiative.

CHOP-led scientists uncovered key details of a basic process in biology: how a cell’s nucleus and chromosome structures reorganize after cell division. The research may offer insights into human health and disease.

The US Food and Drug Administration has approved two new breakthrough therapies for patients with sickle cell disease (SCD), and we believe both may enhance the treatment of our patients here at CHOP.

An unrelenting, deep bone pain that woke him up from sleep is what led to Jake’s diagnosis just last March of Ewing sarcoma, one of the most common bone tumors in children and adolescents.

Three physicians were presented with the Alan R. Cohen Master Clinician Award in CHOP’s Department of Pediatrics.

A 10-month-old female infant underwent neuro-ophthalmic evaluation for a new-onset lid ptosis and pupillary miosis on the right side. There was no history of birth trauma. Vision, eye movements, fundi, and general examination were normal.